Literature DB >> 30611162

Infective endocarditis in patients with pyogenic spondylodiscitis: implications for diagnosis and therapy.

Bedjan Behmanesh1, Florian Gessler1, Katrin Schnoes2, Daniel Dubinski1, Sae-Yeon Won1, Jürgen Konczalla1, Volker Seifert1, Lutz Weise1,3, Matthias Setzer1.   

Abstract

OBJECTIVEThe incidence of patients with pyogenic spinal infection is increasing. In addition to treatment of the spinal infection, early diagnosis of and therapy for coexisting infections, especially infective endocarditis (IE), is an important issue. The aim of this study was to evaluate the proportion of coexisting IE and the value of routine transesophageal echocardiography (TEE) in the management of these patients.METHODSThe medical history, laboratory data, radiographic findings, treatment modalities, and results of TEE of patients admitted between 2007 and 2017 were analyzed.RESULTSDuring the abovementioned period, 110 of 255 total patients underwent TEE for detection of IE. The detection rate of IE between those patients undergoing and not undergoing TEE was 33% and 3%, respectively (p < 0.0001). Thirty-six percent of patients with IE needed cardiac surgical intervention because of severe valve destruction. Chronic renal failure, heart failure, septic condition at admission, and preexisting heart condition were significantly associated with coexisting IE. The mortality rate in patients with IE was significantly higher than in patients without IE (22% vs 3%, p = 0.002).CONCLUSIONSTEE should be performed routinely in all patients with spondylodiscitis.

Entities:  

Keywords:  CI = confidence interval; CRP = C-reactive protein; IDU = intravenous drug use; IE = infective endocarditis; OR = odds ratio; TEE = transesophageal echocardiography; WBC = white blood cell; infective endocarditis; spinal infection; surgery; transesophageal echocardiography

Mesh:

Year:  2019        PMID: 30611162     DOI: 10.3171/2018.10.FOCUS18445

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  4 in total

1.  Incidence, risk factors and clinical course of pyogenic spondylodiscitis patients with pulmonary embolism.

Authors:  Daniel Dubinski; Sae-Yeon Won; Fee Keil; Bedjan Behmanesh; Max Dosch; Peter Baumgarten; Joshua D Bernstock; Volker Seifert; Thomas M Freiman; Florian Gessler
Journal:  Eur J Trauma Emerg Surg       Date:  2021-09-02       Impact factor: 2.374

2.  Vertebral Osteomyelitis and Infective Endocarditis Co-Infection.

Authors:  Tadatsugu Morimoto; Hirohito Hirata; Koji Otani; Eiichiro Nakamura; Naohisa Miyakoshi; Yoshinori Terashima; Kanichiro Wada; Takaomi Kobayashi; Masatoshi Murayama; Masatsugu Tsukamoto; Masaaki Mawatari
Journal:  J Clin Med       Date:  2022-04-18       Impact factor: 4.964

Review 3.  Diagnosis of vertebral osteomyelitis.

Authors:  Julian Maamari; Aaron J Tande; Felix Diehn; Don Bambino Geno Tai; Elie F Berbari
Journal:  J Bone Jt Infect       Date:  2022-01-27

4.  Spontaneous spondylodiscitis and endocarditis: interdisciplinary experience from a tertiary institutional case series and proposal of a treatment algorithm.

Authors:  Lennart Viezens; Marc Dreimann; André Strahl; Annika Heuer; Leon-Gordian Koepke; Benjamin Bay; Christoph Waldeyer; Martin Stangenberg
Journal:  Neurosurg Rev       Date:  2021-09-11       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.